Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 476
Immune Disorders Drugs 202
Drug Discovery 170
Cardiovascular Drugs 157
Infectious Diseases Drugs 135
Biopharmaceuticals 130
Clinical Trials 125
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 85
Hematological Drugs 84
Liver and Kidney Disorders Drugs 79
Lymphoma Drugs 62
Diabetes Drugs 55
Dermatological Drugs 55
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 42
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Drug Delivery 37
Pharmaceutical Intermediates 36
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 32
Infusions and Injectables 30
Liver Cancer Drugs 28
Analgesics 25
Drugs by Therapeutic Area 24
Bladder Cancer Drugs 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Schizophrenia Drugs 19
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Breast Cancer Drugs 14
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Alzheimer's Disease Drugs 8
Optical Disorders Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



274 reviews

2,452 Results (Page 65 of 123)
- Relevance
  Sort by

Fondaparinux - Global Strategic Business Report

 Report
April 2025
93 Pages
Global

From

€5339EUR$5,850USD£4,552GBP

Vasculitis Treatment - Global Strategic Business Report

 Report
April 2025
183 Pages
Global

From

€5339EUR$5,850USD£4,552GBP

Heart Failure Drugs - Global Strategic Business Report

 Report
April 2025
179 Pages
Global

From

€5339EUR$5,850USD£4,552GBP

Heparin - Global Strategic Business Report

 Report
April 2025
184 Pages
Global

From

€5339EUR$5,850USD£4,552GBP

Influenza Vaccine Market by Vaccine Type, Age Group, Administration Route, Distribution Channel - Global Forecast 2025-2030

 Report
October 2024
198 Pages
Global

From

€3235EUR$3,545USD£2,759GBP

€3595EUR$3,939USD£3,065GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Breast Cancer Treatment Market Report and Forecast 2023-2031

 Report
April 2023
147 Pages
Global

From

€4517EUR$4,949USD£3,851GBP

Cardiovascular Drugs - Global Strategic Business Report

 Report
April 2025
413 Pages
Global

From

€5339EUR$5,850USD£4,552GBP

Peripheral Arterial Disease (PAD) Therapeutics - Global Strategic Business Report

 Report
April 2025
188 Pages
Global

From

€5339EUR$5,850USD£4,552GBP

Nasopharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
April 2022
342 Pages
Global

From

€2282EUR$2,500USD£1,945GBP

Anal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
April 2022
216 Pages
Global

From

€1825EUR$2,000USD£1,556GBP

Osteosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
April 2022
316 Pages
Global

From

€2282EUR$2,500USD£1,945GBP

Sinusitis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user and Region (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
July 2023
220 Pages
Global

€4193EUR$4,595USD£3,576GBP

Major Depressive Disorder - Pipeline Insight, 2024

 Clinical Trials
April 2024
180 Pages
Global

From

€2738EUR$3,000USD£2,335GBP

Branded PAH Therapeutics Market (2023 Edition) - Analysis By Drug Class, Route of Administration, Distribution Channel, By Region, By Country: Market Insights and Forecast (2019-2029)

 Report
November 2023
250 Pages
Global

From

€2236EUR$2,450USD£1,907GBP

T-Cell Lymphoma Market Report: Trends, Forecast and Competitive Analysis to 2030

 Report
November 2023
150 Pages
Global

From

€4426EUR$4,850USD£3,774GBP

Antithrombotic/Anticoagulant Drugs: Technologies and Global Markets

 Report
October 2023
157 Pages
Global

From

€4244EUR$4,650USD£3,618GBP

Leukemia Therapeutics Market by Type (CLL, ALL, CML, AML), Treatment Type (Chemotherapy & Targeted Drugs), Mode of Administration (Oral, Injectable), Molecule Type (Small Molecules, Biologics), Gender, and Region - Global Forecast to 2024

 Report
May 2019
126 Pages
Global

From

€4517EUR$4,950USD£3,852GBP

Acute Heart Failure (AHF) Therapeutics - Global Strategic Business Report

 Report
April 2025
299 Pages
Global

From

€5339EUR$5,850USD£4,552GBP

Retinal Drugs Market 2024-2028

 Report
July 2024
180 Pages
Global

From

€2282EUR$2,500USD£1,945GBP

Glucagon-Like Peptide 1 Agonists Market Report: Trends, Forecast and Competitive Analysis to 2030

 Report
January 2024
150 Pages
Global

From

€4426EUR$4,850USD£3,774GBP

2,452 Results (Page 65 of 123)
- 1
- 63
- 64
- 65
- 66
- 67

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.